First Meeting of the EASD Study Group on Genetics of Diabetes (EASD-SGGD)

  • M in M 2007


    "UNDERSTANDING DIABETES IN THE PHARMACOGENOMIC AGE"
    October 4 and 5, 2007
    Malaga , Spain

  • Final Program

    DAY 1 - October 4, 2007

    GENETICS OF TYPE 1 DIABETES

    Chair: LUIS CASTAÑO, Spain

    8:30 - 9:00: In type 1 diabetes, are there nearer-term pathways from genetic and etiological knowledge to prevention?
    JOHN TODD, England

    GENETICS OF TYPE 2 DIABETES

    Chair: JOHN TODD, England, ANDREW T. HATTERSLEY, England

    9:00 - 9:30: New pathways to type 2 diabetes.
    MICHAEL WEEDON, England

    9:30 - 10:00: Type 2 diabetes gene, and now what?
    LEIF GROOP, Sweden


    10:00 - 11:00: Coffee and Poster discussion 1. (Chair: JORGE FERRER, Spain)


    11:00 - 11:30: Quantitative trait related to diabetes and relation with lifestyle.
    OLUF PEDERSEN, Denmark

    11:30 - 12:00: Genome-wide association study in French-Canadian.
    MARTINE VAXILLAIRE, France

    12:00 - 12:30: Genome-wide association study in England.
    MARK McCARTHY, England

    12:30 - 13:00 Oral presentations 1 and 2


    13:00 - 15:00 Lunch and Posters


    MONOGENIC HYPERINSULINISM

    Chair: ANDERS MOLVEN, Norway, ENRIQUE BLAZQUEZ, Spain

    15:00 - 15:30: Two sides of the same gene.
    BEN CLASER, Israel

    15:30 - 16:00: Clinical and pharmacological spectrum of GCK activating mutation.
    ANTONIO L. CUESTA, Spain


    16:00 - 16:30: Coffee


    16:30 - 17:00: Macrosomia and hyperinsulinism caused by mutations in HNF-4a.
    JORGE FERRER, Spain

    17:00 - 17:30: Histological studies of monogenic hyperinsulinism.
    JAQUES RAHIER, Belgium

    DAY 2 - October 5, 2007

    MONOGENIC DIABETES

    Chair: ANTONIO L. CUESTA, Spain, BEN GLASER, Israel

    8:30 - 9:00: Neonatal Diabetes.
    ANDRES T. HATTERSLEY, England

    9:00 - 9:30: Insights into beta-cell function and insulin resistance from naturally occurring mutations.
    ANNA GLOYN, England

    9:30 - 10:00: HNF1B:a wide range of phenotypes and molecular abnormalities.
    CHRISTINE BELLANE-CHANTELOT, France


    10:00 - 11:00: Coffee and Poster discussion 2.(Chair: MICHAEL WEEDON, England)


    11:00 - 11:30: Endocrine or exocrine? Lessons from diabetes caused by CEL mutations.
    ANDERS MOLVEN, Norway

    11:30 - 12:00: When insulin "goes bad":insulin gene mutations and Monogenic Diabetes of Infancy (MDI).
    FABRIZIO BARBETTI, Italy

    12:00 - 12:30: Oral presentations 3 and 4.

    12:30 - 13:00: The impact of genetic testing in monogenic diabetes.
    MAGGIE SHEPHERD, England


    13:00 - 15:00 Lunch and Posters


    EPIGENETICS

    Chair: ANNA GLOYN, England, MARTINE VAXILLAIRE, France

    15:00 - 15:30: A role for epigenetics in complex diseases such as diabetes?
    VARDHMAN K. RAKYAN, England

    15:30 - 16:00: Oral presentations 5 and 6.

    NEWS FROM THE BENCH

    Chair: A. NAVAS, Spain, JAQUES RAHIER, Belgium

    16:00 - 16:30: Endocannabidoid system: New genes for diabetes?
    FERNANDO RODRIGUEZ DE FONSECA, Spain

    16:30 - 17:00: The mitocondrial transcription factor A (TFAM) is a novel Pdx-1 target, explaining impaired insulin secretion in an islet model of MODY4
    CLAES WOLLHEIM, Switzerland

    17:00 - 17:30: Concluding remarks